| Alyse Power, MD | |
|
5377 Manhattan Cir Ste 103, Boulder, CO 80303-4344 | |
| (720) 273-3568 | |
| Not Available |
| Full Name | Alyse Power |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 5377 Manhattan Cir Ste 103, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578941373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 0001140 (Colorado) | Primary |
| 207Q00000X | Family Medicine | 100836 (Alaska) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Three Rivers Medical Center | Grants pass, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asante Physician Partners | 8325206246 | 229 |
News Archive
Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches -rzteblatt International.
In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Despite widespread use of cholesterol-lowering drugs, a significant number of cardiac patients continue to suffer heart attacks and stroke. Researchers theorize that high levels of an enzyme found in coronary plaques may be to blame, by making plaques more likely to rupture and block blood flow. The drug darapladib may offer a way to fight that risk, according to new research led by the University of Pennsylvania School of Medicine.
The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.
› Verified 3 days ago
| Entity Name | Mckenzie Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316909054 PECOS PAC ID: 1254307994 Enrollment ID: O20040903000766 |
News Archive
Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches -rzteblatt International.
In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Despite widespread use of cholesterol-lowering drugs, a significant number of cardiac patients continue to suffer heart attacks and stroke. Researchers theorize that high levels of an enzyme found in coronary plaques may be to blame, by making plaques more likely to rupture and block blood flow. The drug darapladib may offer a way to fight that risk, according to new research led by the University of Pennsylvania School of Medicine.
The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.
› Verified 3 days ago
| Entity Name | Asante Physician Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922381326 PECOS PAC ID: 8325206246 Enrollment ID: O20120223000671 |
News Archive
Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches -rzteblatt International.
In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Despite widespread use of cholesterol-lowering drugs, a significant number of cardiac patients continue to suffer heart attacks and stroke. Researchers theorize that high levels of an enzyme found in coronary plaques may be to blame, by making plaques more likely to rupture and block blood flow. The drug darapladib may offer a way to fight that risk, according to new research led by the University of Pennsylvania School of Medicine.
The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alyse Power, MD 5377 Manhattan Cir Ste 103, Boulder, CO 80303-4344 Ph: (720) 273-3568 | Alyse Power, MD 5377 Manhattan Cir Ste 103, Boulder, CO 80303-4344 Ph: (720) 273-3568 |
News Archive
Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches -rzteblatt International.
In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Despite widespread use of cholesterol-lowering drugs, a significant number of cardiac patients continue to suffer heart attacks and stroke. Researchers theorize that high levels of an enzyme found in coronary plaques may be to blame, by making plaques more likely to rupture and block blood flow. The drug darapladib may offer a way to fight that risk, according to new research led by the University of Pennsylvania School of Medicine.
The Melanoma Research Foundation Breakthrough Consortium has launched a new clinical trial to assess the impact of concomitant administration of bevacizumab (Avastin) with vemurafenib (Zelboraf) in patients with BRAFV600 mutation positive metastatic melanoma.
› Verified 3 days ago
Naomi Y Feiman, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4745 Arapahoe Ave Ste 310, Boulder, CO 80303 Phone: 303-442-2913 | |
Dr. Kartik Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1942 Broadway Ste 314c, Boulder, CO 80302 Phone: 206-801-1656 | |
Tara M Snow, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7610 Fax: 303-415-7618 | |
Diana L Mancini, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7610 Fax: 303-415-7618 | |
Kelly Jean Cushing, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7610 Fax: 303-415-7618 |